Listar por tema "Aspergillus fumigatus"

Ordenar por:Orden:Resultados:

  • Aspergilosis pulmonar secundaria a neutropenia inducida por metimazol: reporte de un caso 
    Pinto, M.E.; Banda Flores, Claudia Lizette; Seas Ramos, Carlos Rafael (Instituto Nacional de Salud, 2012)
    A 48-year old woman with a recent diagnosis of Graves' disease arrived at the emergency room with fever, palpitations, and a sore throat. Her regular treatment included methimazole. On admission, laboratory results showed ...
  • Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru 
    Bustamante Rufino, Ana Beatriz; Illescas, Luis Ricardo; Posadas, Andres; Campos, Pablo E. (Oxford University Press, 2019)
    Azole resistance among Aspergillus fumigatus isolates, which is mainly related to mutations in the cyp51A gene, is a concern because it is rising, worldwide disseminated, and associated with treatment failure and death. ...
  • Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values 
    Espinel-Ingroff, A.; Turnidge, J.; Alastruey-Izquierdo, A.; Dannaoui, E.; Garcia-Effron, G.; Guinea, J.; Kidd, S.; Pelaez, T.; Sanguinetti, M.; Meletiadis, J.; Botterel, F.; Bustamante Rufino, Ana Beatriz; Chen, Y.-C.; Chakrabarti, A.; Chowdhary, A.; Chryssanthou, E.; Córdoba, S.; Gonzalez, G. M.; Guarro, J.; Johnson, E. M.; Kus, J. V.; Lass-Flörl, C.; Linares-Sicilia, M. J.; Martín-Mazuelos, E.; Negri, C. E.; Pfaller, M. A.; Tortorano, A. M. (American Society for Microbiology, 2018)
    Estimating epidemiological cutoff endpoints (ECVs/ECOFFS) may be hindered by the overlap of MICs for mutant and nonmutant strains (strains harboring or not harboring mutations, respectively). Posaconazole MIC distributions ...
  • Triazole resistance prevalence in Aspergillus fumigatus in Mexico and Peru 
    Resendiz-Sharpe, Agustin; Bustamante, Beatriz; Merckx, R.; Jacobs, J.; Maertens,J.; Verweij,P.; Lagrou, K. (Universidad Peruana Cayetano Heredia, 2019)
    Introduction: Triazole-antifungal treatment, the recommended first-line therapy for aspergillosis, is threatened as triazole-resistance reports in Aspergillus fumigatus increase worldwide. Infection by resistant isolates ...
  • Triazole-resistance in environmental aspergillus fumigatus in latin american and african countries 
    Resendiz-Sharpe, A.; Dewaele, K.; Merckx, R.; Bustamante Rufino, Ana Beatriz; Vega-Gomez, M.C.; Rolon, M.; Jacobs, J.; Verweij, P.E.; Maertens, J.; Lagrou, K. (MDPI, 2021)
    Triazole-resistance has been reported increasingly in Aspergillus fumigatus. An international expert team proposed to avoid triazole monotherapy for the initial treatment of invasive aspergillosis in regions with >10% ...

Buscar en el Repositorio

Listar

Panel de Control